Cassia Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
15,031
+843
+6% +$97.3K 0.93% 20
2025
Q4
$1.49M Sell
14,188
-622
-4% -$58.4K 0.81% 25
2025
Q3
$1.24M Buy
14,810
+1,748
+13% +$144K 0.68% 38
2025
Q2
$1.03M Buy
13,062
+527
+4% +$41.9K 0.62% 40
2025
Q1
$1.13M Buy
12,535
+1,340
+12% +$125K 0.7% 32
2024
Q4
$1.11M Buy
11,195
+3,632
+48% +$374K 0.71% 23
2024
Q3
$859K Sell
7,563
-315
-4% -$37.4K 0.57% 24
2024
Q2
$975K Sell
7,878
-705
-8% -$90.8K 0.64% 20
2024
Q1
$1.13M Buy
8,583
+1,087
+15% +$134K 0.75% 17
2023
Q4
$817K Buy
7,496
+273
+4% +$28.3K 0.68% 16
2023
Q3
$744K Buy
7,223
+102
+1% +$11K 0.61% 16
2023
Q2
$822K Buy
7,121
+1,119
+19% +$127K 0.65% 14
2023
Q1
$639K Sell
6,002
-79
-1% -$8.53K 0.51% 17
2022
Q4
$675K Buy
6,081
+1,739
+40% +$178K 0.55% 15
2022
Q3
$374K Sell
4,342
-1,118
-20% -$99.8K 0.34% 19
2022
Q2
$498K Buy
5,460
+30
+0.6% +$2.66K 0.5% 14
2022
Q1
$446K Buy
5,430
+107
+2% +$8.44K 0.36% 22
2021
Q4
$408K Buy
+5,323
New +$424K 0.27% 24
2021
Q3
Sell
-3,033
Closed -$236K 120
2021
Q2
$236K Buy
+3,033
New +$226K 0.18% 29

Other funds holding MRK

Cassia Capital Partners's MRK Position: Q1 2026 in Review

Cassia Capital Partners increased its Merck (MRK) stake by 5.9% in Q1 2026, buying an estimated $97.3K and bringing the position to 15,031 shares worth $1.81M. The position accounts for 0.93% of the portfolio, ranked #20.

Cassia Capital Partners first reported a position in MRK in Q2 2021 and has held it in 19 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cassia Capital Partners held 15,031 shares of Merck worth $1.81M as of Q1 2026.
  • Cassia Capital Partners bought 843 Merck shares in Q1 2026, an estimated $97.3K.
  • Merck made up 0.93% of Cassia Capital Partners's portfolio in Q1 2026, its #20 holding.
  • Cassia Capital Partners first reported a position in Merck in Q2 2021 and has held it in 19 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cassia Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.